AP
ELV icon

AHL Partners’s Elevance Health ELV Stock Holding History

AHL Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$13.3M Buy
59,116
+9,070
+18% +$1.93M 0.21% 97
2017
Q3 		$9.5M Sell
50,046
-32,483
-39% -$6.18M 0.17% 178
2017
Q2 		$15.5M Buy
82,529
+223
+0.3% +$40.1K 0.33% 23
2017
Q1 		$13.6M Buy
82,306
+55,536
+207% +$8.83M 0.3% 23
2016
Q4 		$3.85M Sell
26,770
-3,801
-12% -$509K 0.12% 326
2016
Q3 		$3.83M Sell
30,571
-9,808
-24% -$1.27M 0.14% 225
2016
Q2 		$5.3M Buy
40,379
+32,085
+387% +$4.39M 0.29% 70
2016
Q1 		$1.15M Sell
8,294
-24,293
-75% -$3.25M 0.07% 352
2015
Q4 		$4.54M Buy
32,587
+17,888
+122% +$2.46M 0.35% 83
2015
Q3 		$2.06M Sell
14,699
-43,619
-75% -$6.56M 0.33% 53
2015
Q2 		$9.57M Buy
58,318
+8,869
+18% +$1.42M 0.38% 4
2015
Q1 		$7.63M Buy
49,449
+5,996
+14% +$854K 0.3% 17
2014
Q4 		$5.46M Sell
43,453
-2,566
-6% -$317K 0.28% 20
2014
Q3 		$5.5M Buy
+46,019
New +$5.28M 0.43% 28

Other funds holding ELV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

AHL Partners's ELV Position: Q4 2017 in Review

AHL Partners increased its Elevance Health (ELV) stake by 18% in Q4 2017, buying an estimated $1.93M and bringing the position to 59,116 shares worth $13.3M. The position accounts for 0.21% of the portfolio, ranked #97.

AHL Partners first reported a position in ELV in Q3 2014 and has held it in 14 quarters since. The position peaked at $15.5M in Q2 2017. 910 funds tracked by Wall St. Rank hold ELV as of Q4 2017.

  • AHL Partners held 59,116 shares of Elevance Health worth $13.3M as of Q4 2017.
  • AHL Partners bought 9,070 Elevance Health shares in Q4 2017, an estimated $1.93M.
  • Elevance Health made up 0.21% of AHL Partners's portfolio in Q4 2017, its #97 holding.
  • AHL Partners first reported a position in Elevance Health in Q3 2014 and has held it in 14 quarters since.
  • AHL Partners's Elevance Health position peaked at $15.5M in Q2 2017.
  • 910 funds tracked by Wall St. Rank held Elevance Health as of Q4 2017.

Based on AHL Partners's 13F filing for Q4 2017, filed 14 Feb 2018.